Peter Foley
@foley_p_neuro
Followers
185
Following
2K
Statuses
231
Neurologist, prev @peterfoley10 @AnneRowlClinic |#MS #HuntingtonsDisease #symptoms #pain #palliative | 🏴 🌍 🧠 🔬
Edinburgh Uni
Joined June 2023
RT @MichaelOkun: The randomized trial results are in for the GLP-1 drug Exenatide for Parkinson's disease. Spoiler: NO symptomatic or disea…
0
31
0
RT @ScottishHD: Deadline this Friday! Apply now! ⏳ We are hiring a Specialist Youth Advisor (24 hours per week – Fixed Term until July 202…
0
3
0
RT @AnneRowlClinic: Soon we'll be starting a new research study looking at #MRI imaging of the spinal cord in people with multiple sclerosi…
0
3
0
RT @Brandon_Beaber: Ocrevus vs. Tysabri for MS in an observational propensity matching study. "No significant differences were found...in t…
0
17
0
RT @MSTrust: Finding information you can trust is important, particularly when you're newly diagnosed with #MultipleSclerosis (MS). Learnin…
0
3
0
RT @AnneRowlClinic: 🧠🔬Neuroimmunology & MS 2025, Edinburgh: 11th & 12th March 2025 Two days of talks, discussion & networking with focus…
0
3
0
RT @NHS_Lothian: Due to the Red Alert, NHS Lothian has taken the difficult decision to cancel all routine, non-urgent planned procedures an…
0
10
0
RT @AnneRowlClinic: 1/5 Come & join our team! We integrate the best NHS health care with the best University health research to find & tes…
0
8
0
RT @Mayo_AING: Our new CASPR2 paper is out @ANA_journals 🤩 Headlines: Patients have neuropathic pain & fatigue as their main long term com…
0
19
0
RT @AnneRowlClinic: NeuroCARE, our platform for people in Scotland with a neurological condition, & their carers, has launched! NeuroCARE…
0
5
0
🚨 Subtle changes in the brain 🧠 happen approximately 📅 twenty years before a clinical motor diagnosis in people with Huntington’s disease, finds a new study led by Prof Sarah Tabrizi (UK DRI at UCL), in collaboration with experts at the Universities of Glasgow, Gothenburg, Iowa, and Cambridge. ⭐️The research paves the way for future preventative clinical trials, offering hope for earlier interventions that could preserve brain function and improve outcomes for individuals at risk of Huntington’s. 👏 Read more 👉 @UCLHD @UCLIoN @UCLBrainScience @ucl
0
0
0
Another DMT for RRMS! 🧠 🚨 ⚡
Ublituximab (Briumvi) has been approved as a new disease modifying therapy (DMT) to treat active relapsing remitting MS in England, Wales and Scotland. Read more about Ublituximab (Briumvi) ➡️
0
1
4
RT @NRS_NDN: If you are interested in taking part in #Research for #dementia #Parkinson #MND #Huntingtondisease or #multiplesclerosis, join…
0
2
0
RT @themsguide: Exercise is good for MS. Exercise is good for MS. Exercise is good for MS. Exercise is good for MS. This needs repeating.…
0
2
0
RT @AnneRowlClinic: There’s a wide range of topics at this year’s Neuroimmunology & MS 2025 meeting. To register, submit your abstract & to…
0
3
0
RT @adrianbudhram1: Diagnosing PML relies heavily on CSF JC virus PCR. Our study finds excellent PPV of PCR performed at our national testi…
0
34
0
RT @cfawnsritchie: 🌟PhD Opportunity🌟 Investigate the links between opioids, other analgesics, and cognitive decline and dementia. Supervise…
0
22
0
RT @NHS_Lothian: ‼️ A&E is under extreme pressure If it’s not a critical emergency, you face a very long wait if you come to A&E. If it's…
0
3
0
RT @Brain1878: The benefits of early initiation of disease-modifying therapy in MS are well-established, but when & how to de-escalate trea…
0
29
0